Previous Close | 1.2500 |
Open | 1.2500 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 1.2500 - 1.2500 |
52 Week Range | 0.7700 - 2.2900 |
Volume | |
Avg. Volume | 146 |
Market Cap | 389.866M |
Beta (5Y Monthly) | 1.56 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0700 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for AVCTF
LONDON & WETHERBY, England, March 28, 2023--Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announced the appointment of Karen Harrison as Chief Operating Officer of its Therapeutics Division.
For us, stock picking is in large part the hunt for the truly magnificent stocks. But when you hold the right stock for...
If you want to know who really controls Avacta Group Plc ( LON:AVCT ), then you'll have to look at the makeup of its...